Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Human immunodeficiency virus 1 | Aberrant vpr protein | Starlite/ChEMBL | No references |
Homo sapiens | isocitrate dehydrogenase 1 (NADP+), soluble | Starlite/ChEMBL | No references |
Homo sapiens | TAR DNA binding protein | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | isocitrate dehydrogenase [NADP], mitochondrial precursor, putative | 0.0019 | 0.0086 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0069 | 0.3088 | 0.3088 |
Loa Loa (eye worm) | hypothetical protein | 0.0069 | 0.3088 | 0.3088 |
Trypanosoma brucei | isocitrate dehydrogenase, putative | 0.0019 | 0.0086 | 1 |
Echinococcus granulosus | NADP dependent isocitrate dehydrogenase | 0.0019 | 0.0086 | 0.024 |
Onchocerca volvulus | 0.0182 | 1 | 1 | |
Loa Loa (eye worm) | jmjC domain-containing protein | 0.0066 | 0.2947 | 0.2947 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.357 | 1 |
Echinococcus granulosus | lysine specific histone demethylase 1A | 0.0069 | 0.3088 | 0.8652 |
Brugia malayi | amine oxidase, flavin-containing family protein | 0.002 | 0.0125 | 0.0125 |
Echinococcus multilocularis | isocitrate dehydrogenase | 0.0019 | 0.0086 | 0.024 |
Leishmania major | isocitrate dehydrogenase [NADP], mitochondrial precursor, putative | 0.0019 | 0.0086 | 1 |
Schistosoma mansoni | jumonji/arid domain-containing protein | 0.0066 | 0.2947 | 0.8257 |
Schistosoma mansoni | jumonji domain containing protein | 0.0066 | 0.2947 | 0.8257 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0144 | 0.7676 | 0.7676 |
Echinococcus multilocularis | lysine specific demethylase 5A | 0.0066 | 0.2947 | 0.8257 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.357 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0182 | 1 | 1 |
Echinococcus multilocularis | Transcription factor, JmjC domain containing protein | 0.0066 | 0.2947 | 0.8257 |
Brugia malayi | jmjC domain containing protein | 0.0066 | 0.2947 | 0.2947 |
Toxoplasma gondii | isocitrate dehydrogenase | 0.0019 | 0.0086 | 1 |
Trypanosoma cruzi | isocitrate dehydrogenase, putative | 0.0019 | 0.0086 | 1 |
Brugia malayi | RNA binding protein | 0.0076 | 0.357 | 0.357 |
Echinococcus granulosus | tar DNA binding protein | 0.0076 | 0.357 | 1 |
Schistosoma mansoni | jumonji/arid domain-containing protein | 0.0066 | 0.2947 | 0.8257 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0019 | 0.0086 | 0.024 |
Loa Loa (eye worm) | isocitrate dehydrogenase | 0.0019 | 0.0086 | 0.0086 |
Schistosoma mansoni | NADP-specific isocitrate dehydrogenase | 0.0019 | 0.0086 | 0.024 |
Mycobacterium tuberculosis | Probable isocitrate dehydrogenase [NADP] Icd1 (oxalosuccinate decarboxylase) (IDH) (NADP+-specific ICDH) (IDP) | 0.0019 | 0.0086 | 0.5 |
Schistosoma mansoni | Lysine-specific histone demethylase 1 | 0.0069 | 0.3088 | 0.8652 |
Brugia malayi | jmjC domain containing protein | 0.0066 | 0.2947 | 0.2947 |
Trypanosoma brucei | isocitrate dehydrogenase [NADP], mitochondrial precursor, putative | 0.0019 | 0.0086 | 1 |
Plasmodium vivax | isocitrate dehydrogenase [NADP], mitochondrial, putative | 0.0019 | 0.0086 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.002 | 0.0125 | 0.0125 |
Brugia malayi | MH2 domain containing protein | 0.0144 | 0.7676 | 0.7676 |
Loa Loa (eye worm) | TAR-binding protein | 0.0076 | 0.357 | 0.357 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.357 | 1 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0076 | 0.357 | 0.357 |
Plasmodium falciparum | isocitrate dehydrogenase [NADP], mitochondrial | 0.0019 | 0.0086 | 1 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0144 | 0.7676 | 0.7676 |
Echinococcus multilocularis | tar DNA binding protein | 0.0076 | 0.357 | 1 |
Brugia malayi | SWIRM domain containing protein | 0.0074 | 0.344 | 0.344 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0076 | 0.357 | 0.357 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.357 | 1 |
Loa Loa (eye worm) | RNA binding protein | 0.0076 | 0.357 | 0.357 |
Echinococcus granulosus | lysine specific demethylase 5A | 0.0066 | 0.2947 | 0.8257 |
Brugia malayi | TAR-binding protein | 0.0076 | 0.357 | 0.357 |
Brugia malayi | isocitrate dehydrogenase | 0.0019 | 0.0086 | 0.0086 |
Echinococcus granulosus | Transcription factor JmjC domain containing protein | 0.0066 | 0.2947 | 0.8257 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0019 | 0.0086 | 0.024 |
Loa Loa (eye worm) | hypothetical protein | 0.0074 | 0.344 | 0.344 |
Brugia malayi | Isocitrate dehydrogenase | 0.0019 | 0.0086 | 0.0086 |
Echinococcus multilocularis | isocitrate dehydrogenase 2 (NADP+) | 0.0019 | 0.0086 | 0.024 |
Echinococcus multilocularis | lysine specific histone demethylase 1A | 0.0069 | 0.3088 | 0.8652 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.357 | 1 |
Toxoplasma gondii | isocitrate dehydrogenase | 0.0019 | 0.0086 | 1 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0019 | 0.0086 | 0.024 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 3.5481 uM | PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 6.5131 uM | PubChem BioAssay. qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 10 uM | PubChem BioAssay. qHTS Assay for Inhibitors of the HIV-1 protein Vpr. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 50.1187 uM | PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 79.4328 uM | PubChem BioAssay. qHTS for Antagonist of cAMP-regulated guanine nucleotide exchange factor 3 (EPAC1): primary screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.